Tag: Prostate Cancer
-
It’s different for everyone: From fighting fires to fighting cancer
Introduction: A routine moment that changed everything When a fit, active firefighter receives a diagnosis that changes the course of their life, the shock isn’t just personal—it echoes through families, colleagues, and communities. This is the story of Connell, a member of the Dublin Fire Brigade, whose experience with prostate cancer began with a routine…
-
When a Cancer Diagnosis Changes a Couple: Tough Talks, Tough Choices, and Growing Closer
H2: A Diagnosis That Changes the Conversation A cancer diagnosis can upend routines, plans, and even the words a couple uses with each other. For many couples, the moment of discovery is followed by a second, equally consequential moment: the realization that the relationship will be tested in ways that medical charts alone cannot capture.…
-
PSA Screening Improves Survival: ERSPC Trial Findings
New Evidence Highlights PSA Screening Benefits A landmark update from the European Randomised Study of Screening for Prostate Cancer (ERSPC) confirms that sustained, protocol-driven PSA testing can reduce mortality from prostate cancer and improve the overall benefit-to-harm ratio. The new findings reinforce the value of personalized, risk-based screening strategies that prioritize patient safety and informed…
-
PSA Screening Shown to Improve Survival and Safety in 23-Year ERSPC Trial
Overview of a Groundbreaking 23-Year Study Researchers conducting the European Randomized Study of Screening for Prostate Cancer (ERSPC) have released long-awaited findings from 23 years of follow-up. The results indicate that sustained, protocolized PSA testing can reduce deaths from prostate cancer and, crucially, improve the balance between benefits and harms for many men. This work…
-
Study confirms PSA screening improves survival and safety
Key takeaway: PSA screening improves outcomes Prostate cancer remains a major health concern worldwide, but new results from the 23-year European Randomized Study of Screening for Prostate Cancer (ERSPC) reinforce a core message: sustained, protocol-driven PSA screening saves lives. The long-term data show not only a reduction in prostate cancer mortality but also a more…
-
Blocking PDIA1 and PDIA5: A Double Hit Shakes Up Prostate Cancer Therapy
New vulnerability in prostate cancer identified A multinational team of scientists has uncovered a promising vulnerability in prostate cancer cells that could improve how the disease is treated. In a study published in Proceedings of the National Academy of Sciences (PNAS), researchers from Flinders University in Australia and South China University of Technology demonstrate that…
-
Can a Cholesterol Drug Help Fight Advanced Prostate Cancer? What Statins Do When Used With Apalutamide
Can a cholesterol drug really help fight advanced prostate cancer? Yes, according to a new analysis, statins — the widely used cholesterol-lowering medications — may help some men with advanced prostate cancer live longer when paired with apalutamide and standard hormone therapy. The finding, published in the European Medical Journal, looked at data from more…
-
Blocking PDIA1 and PDIA5: A New Strategy to Weaken Prostate Tumors and Boost Drug Effectiveness
New vulnerability in prostate cancer identified: two enzymes that protect the androgen receptor A major international study has uncovered a promising vulnerability in prostate cancer cells that could improve treatment for one of the most common cancers in men. Published in the Proceedings of the National Academy of Sciences (PNAS), the research shows that two…
-
Blocking two enzymes weakens prostate tumors and boosts drug effectiveness
New vulnerability uncovered in prostate cancer: targeting PDIA1 and PDIA5 A major international study has identified a promising vulnerability in prostate cancer cells that could improve how this common male cancer is treated. Published in the Proceedings of the National Academy of Sciences (PNAS), researchers from Flinders University in Australia and the South China University…
-
Statins May Extend Survival in Advanced Prostate Cancer
Can a cholesterol drug really help fight prostate cancer? A new study suggests that cholesterol-lowering statins might do more than manage cholesterol levels. When used alongside apalutamide and standard hormone therapy, statins could help men with advanced prostate cancer live longer. The finding, reported in European Medical Journal, comes from a large analysis of more…